Max Healthcare shareholders approve ₹2 dividend, Haryana office shift

2 min read     Updated on 30 Jul 2026, 07:20 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Max Healthcare Institute Limited held its 25th AGM on July 30, 2026, where shareholders approved a final dividend of ₹2 per share and the relocation of the registered office to Haryana. The meeting also saw the re-appointment of Anil Kumar Bhatnagar and ratification of auditor fees, with all resolutions passing with significant majority support.

powered bylight_fuzz_icon
46962187

*this image is generated using AI for illustrative purposes only.

Max Healthcare Institute shareholders approved a final dividend of ₹2 per equity share and authorized the relocation of the company’s registered office from Maharashtra to Haryana during its 25th Annual General Meeting (AGM) held on July 30, 2026. The meeting, conducted via video conference, also saw the re-appointment of Anil Kumar Bhatnagar as a director and the ratification of auditor remuneration. The resolutions were passed with overwhelming support, reflecting strong shareholder confidence in the company’s strategic direction and governance framework.

The AGM was chaired by Abhay Soi, Chairman and Managing Director, who highlighted operational progress in FY26, including capacity expansions in Mohali, Mumbai, and Delhi. He noted the recent acquisition of a 58.28% stake in Kalinga Hospital Limited, now Max Super Speciality Hospital, Bhubaneswar, which strengthens the company’s presence in eastern India. Soi emphasized strategic investments in robotic-assisted surgery, AI-driven clinical workflows, and renewable energy infrastructure as key drivers of long-term value creation.

Voting Results Summary

Shareholders transacted both ordinary and special business items. The following table summarizes the voting outcomes for key resolutions:

Resolution Description Type Votes in Favor (%) Votes Against (%)
Adoption of Audited Standalone Financial Statements for FY26 Ordinary 99.9997% 0.0003%
Adoption of Audited Consolidated Financial Statements for FY26 Ordinary 99.9997% 0.0003%
Declaration of Final Dividend of ₹2 per equity share Ordinary 99.9997% 0.0003%
Re-appointment of Anil Kumar Bhatnagar by rotation Special 97.7254% 2.2746%
Approval of remuneration for Non-Executive Directors Ordinary 99.9076% 0.0924%
Re-appointment of Anil Kumar Bhatnagar as Non-Executive Director Special 97.3803% 2.6197%
Shifting registered office from Maharashtra to Haryana Special 99.9991% 0.0009%
Ratification of Cost Auditor remuneration for FY27 Ordinary 99.9997% 0.0003%

Governance and Compliance

Dhiraj Aroraa, Executive Vice President - Company Secretary and Compliance Officer, confirmed that the company complied with all statutory provisions during FY26. He stated that there were no qualifications or adverse remarks in the Statutory Auditor’s Report issued by S.R. Batliboi & Co. LLP or the Secretarial Auditor’s Report issued by DPV & Associates LLP. Chandra Wadhwa & Co. served as the Cost Auditors.

A quorum of 160 members was present via video conference. The Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee chairs attended to address shareholder queries. Voting was conducted through MUFG Intime India Private Limited using remote e-voting and InstaVote platforms, with Devesh Kumar Vasisht of DPV & Associates LLP acting as Scrutinizer. The cut-off date for voting eligibility was July 23, 2026, with a total of 234,355 shareholders on record.

What the Numbers Show

The declaration of a ₹2 final dividend per equity share, representing 20% of the face value, signals continued cash generation despite significant capital expenditure on hospital expansions and acquisitions. The simultaneous approval of the registered office shift to Haryana suggests a strategic alignment with the company’s operational headquarters in New Delhi, potentially streamlining corporate governance and administrative efficiency. The high approval rates for director re-appointments, despite some dissent from institutional investors, indicate overall trust in the board’s leadership.

Historical Stock Returns for Max Healthcare Institute

1 Day5 Days1 Month6 Months1 Year5 Years
+1.21%+4.05%-2.18%+18.08%-11.73%+307.24%

How will the relocation of the registered office to Haryana impact Max Healthcare's tax liabilities and regulatory compliance costs in the long term?

What is the expected timeline for the full integration of the acquired Kalinga Hospital into Max Healthcare's eastern India network, and how will this affect regional market share?

Given the significant capital expenditure on robotic surgery and AI workflows, what is the projected ROI timeline for these technology investments?

Max Healthcare Institute
View Company Insights
View All News
like16
dislike

NCLT adjourns BRS Capital petitions against Max Healthcare's Kalinga Hospital to Aug 4

1 min read     Updated on 26 Jul 2026, 09:33 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Max Healthcare Institute Ltd. reported that the National Company Law Tribunal (NCLT), Cuttack Bench, has deferred the next hearing on petitions filed by BRS Capital Two Pte. Limited against its subsidiary, Kalinga Hospital Ltd., to August 4, 2026. The petitions also name Max Healthcare Institute and another shareholder from whom the majority equity stake was acquired. No settlement has been reached, and the filing was made under Regulation 30 of SEBI LODR Regulations.

powered bylight_fuzz_icon
46421107

*this image is generated using AI for illustrative purposes only.

Max Healthcare Institute disclosed on July 24, 2026, that the National Company Law Tribunal (NCLT), Cuttack Bench, has adjourned the hearing on petitions filed by BRS Capital Two Pte. Limited against its subsidiary, Kalinga Hospital Ltd. The tribunal listed the matter on July 23, 2026, at 2:30 pm IST and subsequently deferred the next hearing to August 4, 2026. This development follows earlier intimations by the company dated May 19, 2026, and July 8, 2026, regarding the legal proceedings initiated by the legal representatives of BRS Capital Two Pte. Limited.

Legal Proceedings Status

The petitions involve Kalinga Hospital Ltd., a subsidiary of Max Healthcare Institute, as well as the company itself and the other shareholder from whom Max Healthcare acquired the majority equity stake in Kalinga Hospital. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that no settlement has been reached and provides no further details on the specific nature or grounds of the petitions beyond their listing before the tribunal.

Parameter: Details
Tribunal: National Company Law Tribunal (NCLT), Cuttack Bench
Petitioner: BRS Capital Two Pte. Limited
Respondents: Kalinga Hospital Ltd., Max Healthcare Institute Ltd., Other Shareholder
Last Hearing Date: July 23, 2026
Next Hearing Date: August 4, 2026

Regulatory Disclosure

The company stated that this disclosure continues its previous notifications regarding the ongoing litigation. The details were submitted to both the National Stock Exchange of India Limited and BSE Limited. The filing does not indicate any immediate financial impact or change in the status of the proceedings other than the procedural adjournment. Stakeholders are advised to monitor the outcome of the hearing scheduled for August 4, 2026, for any material developments in the case.

Historical Stock Returns for Max Healthcare Institute

1 Day5 Days1 Month6 Months1 Year5 Years
+1.21%+4.05%-2.18%+18.08%-11.73%+307.24%

What specific legal arguments or evidence is BRS Capital Two Pte. Limited expected to present at the August 4 hearing that could alter the case trajectory?

How might a prolonged litigation process impact Max Healthcare's ability to integrate Kalinga Hospital Ltd. into its broader operational strategy?

Could the outcome of this NCLT proceeding set a precedent for how minority shareholder disputes are resolved in India's healthcare sector?

Max Healthcare Institute
View Company Insights
View All News
like19
dislike

More News on Max Healthcare Institute

1 Year Returns:-11.73%